A Study of Combination of Daratumumab and Velcade (Bortezomib) Melphalan-Prednisone (DVMP) Compared to Velcade Melphalan-Prednisone (VMP) in Participants With Previously Untreated Multiple Myeloma
Clinical trial NCT02195479 · COMPLETED
Trial details
- NCT number
- NCT02195479
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-09
- Primary completion
- 2017-11-21
- Enrollment
- 706
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.